Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

INAB

IN8bio (INAB)

IN8bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INAB
DateTimeSourceHeadlineSymbolCompany
11/03/20229:10AMGlobeNewswire Inc.IN8bio to Present Positive Early Data from Ongoing Phase 1 Study of INB-100 at the 64th American Society of Hematology Annual MeetingNASDAQ:INABIN8bio Inc
11/01/20227:30AMGlobeNewswire Inc.IN8bio to Present at November Investor ConferencesNASDAQ:INABIN8bio Inc
10/25/20224:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INABIN8bio Inc
10/25/20224:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INABIN8bio Inc
09/27/20227:30AMGlobeNewswire Inc.IN8bio to Present at Cantor Oncology & HemOnc ConferenceNASDAQ:INABIN8bio Inc
09/23/20225:10PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:INABIN8bio Inc
09/23/20225:07PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:INABIN8bio Inc
09/23/20225:06PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:INABIN8bio Inc
09/15/20227:30AMGlobeNewswire Inc.IN8bio Partners with the Dunbar CAR T-Cell Program at the University of Louisville as the Manufacturing Center for INB-400NASDAQ:INABIN8bio Inc
09/13/20227:30AMGlobeNewswire Inc.IN8bio to Present at H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:INABIN8bio Inc
09/08/20227:30AMGlobeNewswire Inc.IN8bio Appoints Michael R. Bishop, M.D., to Its Scientific Advisory BoardNASDAQ:INABIN8bio Inc
08/30/20224:15PMGlobeNewswire Inc.IN8bio to Present at September Investor and Scientific ConferencesNASDAQ:INABIN8bio Inc
08/30/20228:11AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INABIN8bio Inc
08/19/20224:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INABIN8bio Inc
08/19/20229:20AMGlobeNewswire Inc.IN8bio Announces Closing of Exercise Option to Purchase Additional Shares in Public OfferingNASDAQ:INABIN8bio Inc
08/18/20227:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INABIN8bio Inc
08/18/20224:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INABIN8bio Inc
08/18/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INABIN8bio Inc
08/18/20224:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INABIN8bio Inc
08/18/20224:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INABIN8bio Inc
08/18/20224:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INABIN8bio Inc
08/18/20224:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INABIN8bio Inc
08/17/202210:26AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INABIN8bio Inc
08/16/20224:15PMGlobeNewswire Inc.IN8bio Announces Closing of $10.25 Million Underwritten Public Offering of Common StockNASDAQ:INABIN8bio Inc
08/15/20224:25PMTipRanksMizuho Securities Reaffirms Their Buy Rating on IN8bio (INAB)NASDAQ:INABIN8bio Inc
08/15/20226:36AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:INABIN8bio Inc
08/12/20224:22PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INABIN8bio Inc
08/12/20224:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INABIN8bio Inc
08/12/20224:15PMGlobeNewswire Inc.IN8bio Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:INABIN8bio Inc
08/11/202210:05PMGlobeNewswire Inc.IN8bio Announces Pricing of $10.25 Million Underwritten Public Offering of Common StockNASDAQ:INABIN8bio Inc
 Showing the most relevant articles for your search:NASDAQ:INAB

Your Recent History

Delayed Upgrade Clock